"8 New Square is undoubtedly one of the leading sets for trade mark and copyright cases within the media and entertainment sphere, so much so that stablemates here frequently find themselves pitted against each other in major cases."
Chambers & Partners (Media & Entertainment) 2014
'A number of great IT and telecoms barristers.'
Legal 500 2010
"Fantastic roster of talent" and recommended for being "very modern, forward-thinking and providing sound commercial advice" as well as offering instructing solicitors "a very broad skill set in the soft IP space."
Chambers & Partners 2017
'excellence on IT matters'
Legal 500 (Information Technology) 2010
"8 New Square brims with barristers experienced in fighting fiendishly complex, high-value IT and telecoms disputes."
Chambers & Partners (Information Technology) 2014
'Practical and helpful clerks" provide a "smooth and personable service.'
Chambers and Partners 2011
"an impressive set with quality from the top
silk down to the most junior barristers."
Chambers & Partners (Information Technology) 2013
'Top drawer IP set.'
Legal 500 2010
The clerks are described as "helpful," "generous" and "very good at knowing what you want."
Chambers & Partners (Intellectual Property) 2013
"There are great people there at all levels and the clerks are very accommodating."
Chambers & Partners (Intellectual property) 2014
'A veritable powerhouse of IP expertise'
Chambers and Partners 2011
'An incredibly good set for IP matters'.
Legal 500 2010
"8 New Square brims with barristers experienced in fighting fiendishly complex, high-value IT and telecoms disputes."
Chambers & Partners 2014
Generics (UK) Ltd v Yeda Research & Development Co Ltd [2012] EWHC 1848 (Pat)
Case Summary | Judgment | 11 July 2012
On 11 July 2012 Mr Justice Arnold gave judgment in Mylan v Yeda & Teva, a case concerning the validity and infringement of a patent concerning glatiramer acetate (sold as Copaxone for the treatment of multiple sclerosis). The case raised a large number of issues including both classic and Agrevo-type obviousness, various grounds of insufficiency, claim construction and infringement. Michael Tappin QC and Lindsay Lane (together with Piers Acland QC) acted for Mylan. The appeal is due to be heard in June 2013.